Lei Pei Selected Research

Death-Associated Protein Kinases

10/2020	Death-associated Protein Kinase 1 Mediates Ventilator-induced Lung Injury in Mice by Promoting Alveolar Epithelial Cell Apoptosis.
1/2020	Presynaptic Caytaxin prevents apoptosis via deactivating DAPK1 in the acute phase of cerebral ischemic stroke.
4/2018	Genetic Mutation of GluN2B Protects Brain Cells Against Stroke Damages.
1/2018	DAPK1-ERK signal mediates oxygen glucose deprivation reperfusion induced apoptosis in mouse N2a cells.
1/2017	DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies.
10/2014	Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Pei Research Topics

Disease

12	Stroke (Strokes) 07/2022 - 10/2014
12	Neoplasms (Cancer) 01/2021 - 01/2007
6	Infections 01/2021 - 03/2003
6	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2007
6	Ischemia 04/2018 - 06/2011
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2016
4	Neuroinflammatory Diseases 07/2022 - 01/2017
4	Pain (Aches) 08/2021 - 03/2007
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 09/2015
4	Ischemic Stroke 01/2020 - 09/2015
4	Neoplasm Metastasis (Metastasis) 11/2016 - 01/2007
3	Obesity 01/2021 - 08/2018
3	Sepsis (Septicemia) 01/2021 - 01/2018
3	COVID-19 10/2020 - 01/2020
3	Brain Injuries (Brain Injury) 01/2020 - 07/2015
3	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2018
3	Inflammation (Inflammations) 01/2018 - 12/2010
2	Cognitive Dysfunction 01/2021 - 01/2018
2	Autistic Disorder (Autism) 01/2021 - 01/2021
2	Triple Negative Breast Neoplasms 11/2018 - 02/2016
2	Type 2 Diabetes Mellitus (MODY) 08/2018 - 06/2012
2	Wounds and Injuries (Trauma) 01/2018 - 09/2015
2	Brain Ischemia (Cerebral Ischemia) 03/2016 - 06/2011
2	Reperfusion Injury 03/2016 - 01/2016
2	Infarction (Infarctions) 03/2016 - 09/2015
2	Lymphatic Metastasis 05/2014 - 02/2011
2	Hyperalgesia 07/2012 - 03/2007
1	Acute Promyelocytic Leukemia 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Osteoporosis 11/2021
1	Postmenopausal Osteoporosis 11/2021
1	Autism Spectrum Disorder 01/2021
1	AIDS-Related Complex (ARC) 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Neurodevelopmental Disorders 01/2021
1	Ventilator-Induced Lung Injury 10/2020
1	Congenital Abnormalities (Deformity) 01/2020
1	Hypercalciuria 01/2020
1	Nephrocalcinosis 01/2020
1	Kidney Calculi (Kidney Stone) 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2010
6	Death-Associated Protein KinasesIBA 10/2020 - 10/2014
4	Therapeutic UsesIBA 11/2021 - 10/2014
4	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2014
4	Antiviral Agents (Antivirals)IBA 01/2021 - 05/2014
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2014
3	Pharmaceutical PreparationsIBA 11/2021 - 11/2018
3	Phosphotransferases (Kinase)IBA 01/2021 - 11/2015
3	CalciumIBA 01/2020 - 06/2011
3	Sirtuin 1IBA 05/2019 - 01/2018
3	Peptides (Polypeptides)IBA 07/2018 - 10/2014
3	N-Methylaspartate (NMDA)IBA 04/2018 - 12/2014
3	Glutamic Acid (Glutamate)FDA Link 04/2018 - 12/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2011
2	Metformin (Glucophage)FDA LinkGeneric 11/2021 - 01/2021
2	Analgesics (Analgesic Drugs)IBA 08/2021 - 12/2010
2	EndocannabinoidsIBA 01/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 12/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2020
2	Claudin-2IBA 01/2020 - 01/2016
2	nicotinamide-beta-ribosideIBA 05/2019 - 01/2018
2	AdipokinesIBA 01/2019 - 09/2018
2	Biological ProductsIBA 01/2019 - 05/2014
2	InflammasomesIBA 08/2018 - 01/2017
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2018 - 12/2014
2	LipidsIBA 01/2018 - 03/2016
2	Oxygen (Dioxygen)IBA 01/2018 - 06/2011
2	ParvalbuminsIBA 10/2016 - 07/2015
2	Eosine Yellowish-(YS) (Eosin)IBA 03/2016 - 07/2012
2	triphenyltetrazoliumIBA 03/2016 - 09/2015
1	Eukaryotic Initiation Factor-4EIBA 07/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	Sodium-Calcium ExchangerIBA 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	Sirtuin 3IBA 11/2021
1	HMGB2 ProteinIBA 06/2021
1	RNA (Ribonucleic Acid)IBA 06/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	MetalsIBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020
1	DiamondIBA 04/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Complement Factor D (Factor D)IBA 01/2019
1	AdiponectinIBA 01/2019
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2019
1	LeptinIBA 01/2019
1	Drug CombinationsIBA 01/2019

Therapy/Procedure

10	Therapeutics 06/2021 - 04/2008
1	Decompression 01/2020
1	Drug Therapy (Chemotherapy) 11/2018